Data-driven individualized decision making has recently received increasing research interest. However, most existing methods rely on the assumption of no unmeasured confounding, which cannot be ensured in practice especially in observational studies. Motivated by the recently proposed proximal causal inference, we develop several proximal learning methods to estimate optimal individualized treatment regimes (ITRs) in the presence of unmeasured confounding. Explicitly, in terms of two types of proxy variables, we are able to establish several identification results for different classes of ITRs respectively, exhibiting the trade-off between the risk of making untestable assumptions and the potential improvement of the value function in decision making. Based on these identification results, we propose several classification-based approaches to finding a variety of restricted in-class optimal ITRs and establish their theoretical properties. The appealing numerical performance of our proposed methods is demonstrated via extensive simulation experiments and a real data application.
Spleen tyrosine kinase (SYK) is a previously unidentified therapeutic target that inhibits neutrophil and macrophage activation in coronavirus disease 2019 (COVID-19). Fostamatinib, a SYK inhibitor, was studied in a phase 2 placebo-controlled randomized clinical trial and was associated with improvements in many secondary end points related to efficacy. Here, we used a multiomic approach to evaluate cellular and soluble immune mediator responses of patients enrolled in this trial. We demonstrated that SYK inhibition was associated with reduced neutrophil activation, increased circulation of mature neutrophils (CD10 + CD33 − ), and decreased circulation of low-density granulocytes and polymorphonuclear myeloid-derived suppressor cells (HLA-DR − CD33 + CD11b − ). SYK inhibition was also associated with normalization of transcriptional activity in circulating monocytes relative to healthy controls, an increase in frequency of circulating nonclassical and HLA-DR hi classical monocyte populations, and restoration of interferon responses. Together, these data suggest that SYK inhibition may mitigate proinflammatory myeloid cellular and soluble mediator responses thought to contribute to immunopathogenesis of severe COVID-19.
The repair of exercise-induced muscle damage (EIMD) is closely related with inflammation. Branched-chain amino acids (BCAAs), as a nutritional supplement, promote EIMD repair; however, the underlying mechanism remains unclear. In vivo, Sprague–Dawley rats were subjected to Armstrong’s eccentric exercise (a 120-min downhill run with a slope of −16° and a speed of 16 m min−1) to induce EIMD and BCAA supplement was administered by oral gavage. Protein expression of macrophages (CD68 and CD163) and myogenic regulatory factors (MYOD and MYOG) in gastrocnemius was analyzed. Inflammatory cytokines and creatine kinase (CK) levels in serum was also measured. In vitro, peritoneal macrophages from mice were incubated with lipopolysaccharide (LPS) or IL-4 with or without BCAAs in culture medium. For co-culture experiment, C2C12 cells were cultured with the conditioned medium from macrophages prestimulated with LPS or IL-4 in the presence or absence of BCAAs. The current study indicated BCAA supplementation enhanced the M1/M2 polarization of macrophages in skeletal muscle during EIMD repair, and BCAAs promoted M1 polarization through enhancing mTORC1-HIF1α-glycolysis pathway, and promoted M2 polarization independently of mTORC1. In addition, BCAA-promoted M1 macrophages further stimulated the proliferation of muscle satellite cells, whereas BCAA-promoted M2 macrophages stimulated their differentiation. Together, these results show macrophages mediate the BCAAs’ beneficial impacts on EIMD repair via stimulating the proliferation and differentiation of muscle satellite cells, shedding light on the critical role of inflammation in EIMD repair and the potential nutritional strategies to ameliorate muscle damage.
14 March 2022 in Journal of the American Statistical Association
Measuring and testing the dependency between multiple random functions is often an important task in functional data analysis. In the literature, a model-based method relies on a model which is subject to the risk of model misspecification, while a model-free method only provides a correlation measure which is inadequate to test independence. In this paper, we adopt the Hilbert–Schmidt Independence Criterion (HSIC) to measure the dependency between two random functions. We develop a two-step procedure by first pre-smoothing each function based on its discrete and noisy measurements and then applying the HSIC to recovered functions. To ensure the compatibility between the two steps such that the effect of the pre-smoothing error on the subsequent HSIC is asymptotically negligible when the data are densely measured, we propose a new wavelet thresholding method for pre-smoothing and to use Besov-norm-induced kernels for HSIC. We also provide the corresponding asymptotic analysis. The superior numerical performance of the proposed method over existing ones is demonstrated in a simulation study. Moreover, in a magnetoencephalography (MEG) data application, the functional connectivity patterns identified by the proposed method are more anatomically interpretable than those by existing methods.
20 June 2022 in JACC: Cardiovascular Interventions
In prior studies of cumulative risk factor exposure, self-identified race was independently associated with incident cardiovascular disease (CVD). A recent study suggests clinical, demographic, and socioeconomic factors explain racial differences. We used propensity score matching to study race as an independent incident CVD risk factor. The purpose of this study was to assess race as an independent risk factor for incident CVD. We analyzed CARDIA (Coronary Artery Risk Development in Young Adults) study data using propensity score matching of White and Black women, and, separately, White and Black men, with respect to known CVD risk factors. Black men (n = 487), compared to White men (n = 487), had higher risk of CVD (HR: 2.30; 95% CI: 1.36-3.89; P = 0.0014), stroke (HR: 5.00; 95% CI: 1.45-17.3; P = 0.0047), and congestive heart failure (CHF) (HR: 3.60; 95% CI: 1.34-9.70; P = 0.0067). Black women (n = 640), compared to White women (n = 640), had higher CVD risk (HR: 2.36; 95% CI: 1.17-4.78; P = 0.014) and stroke risk (HR: 2.80; 95% CI: 1.01-7.77; P = 0.039) and borderline significantly higher CHF risk (HR: 3.50; 95% CI: 0.73-16.9; P = 0.096). Risk of coronary heart disease did not differ significantly by race in either sex. Multivariable analyses showed racial differences in the associations of multiple risk factors with incident CVD events independent of other known CVD risk factors. Propensity score matching analyses demonstrate that race is an independent risk factor for incident CVD and its components, CHF, and stroke. Multivariable analyses suggest racial differences in Black vs White risk factor impact as the possible cause. Reasons for these differences remain to be explored.